2318384
Results of ALLEVIATE 1 and ALLEVIATE 2 Phase 3 trials of cebranopadol, a first-in-class, dual NOP/MOP receptor agonist for the treatment of acute pain after abdominoplasty and bunionectomy
Todd Bertoch, Megan Shram, James Hackworth, Joseph Grieco, Harold Minkowitz
Tris Pharma, Inc., CenExel Clinical Research, Altreos Research Partners, Inc., Evolution Research Group
Poster Presenter: David Fam